Evidence map›Paper›PMID 39724216›Full record

ReviewPlant cell reports2024

Exploiting lipid droplet metabolic pathway to foster lipid production: oleosin in focus.

Manmehar Kaur, Kshitija Sinha, Peter J Eastmond, Rupam Kumar Bhunia

Abstract readReview
PubMed Publisher
In one paragraph

Review in Plant cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manmehar Kaur *Department of Biotechnology, Panjab University, Sector-25, Chandigarh, 160014, India.
Kshitija Sinha *Department of Biotechnology, Panjab University, Sector-25, Chandigarh, 160014, India.
Peter J EastmondRothamsted Research, Harpenden, AL5 2JQ, UK.
Rupam Kumar BhuniaNational Agri-Food and Biomanufacturing Institute (NABI), Sector 81, Knowledge City, S.A.S. Nagar, Mohali, Punjab, 140306, India. rupamb2005@gmail.com.ORCID http://orcid.org/0000-0001-7303-5050

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, there has been an emerging gap between the demand and supply of vegetable oils globally for both edible and industrial use. Lipids are important biomolecules with enormous applications in the industrial sector and a major source of energy for animals and plants. Hence, to elevate the lipid content through metabolic engineering, new strategies have come up for triacylglycerol (TAG) accumulation and in raising the lipid or oil yield in crop plants. Increased levels of energy density can be achieved by single and multiple gene strategies that re-orient the carbon flux into TAG. Transcription factors and enzymes of the metabolic pathways have been targeted to foster lipid production. Oleosin, a structural protein of the lipid droplet plays a vital role in its stabilization and subsequently in its mobilization for seed germination and seedling growth. Maintenance of increased lipid content with optimal composition is a major target. Knowledge gained from genetic engineering strategies suggests that oleosin co-expression can result in a significant shift in carbon allocation to LDs. In this review, we present a detailed analysis of the recent advancements in metabolic engineering of plant lipids with emphasis on oleosin with its distinct patterns and functions in plants.

Indexed as

Lipid DropletsMetabolic EngineeringPlant ProteinsGene Expression Regulation, PlantLipid MetabolismMetabolic Networks and PathwaysPlant OilsTriglyceridesPlant OilsPlant ProteinsTriglyceridesLipaseLipid degradationLipid dropletMetabolic engineeringOleosinTriacylglycerol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.